Santhera Pharmaceuticals
SANN.SW$213M
Micro CapSIXBiotechnology🇺🇸North America78 employees
Drugs in Pipeline
3
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
SANN.SW News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
Idebenone
Friedreich's Ataxia
Vamorolone
Duchenne Muscular Dystrophy
POL6014
Cystic Fibrosis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Idebenone | Phase 3 | Friedreich's Ataxia | - | - |
Vamorolone | Phase 2 | Duchenne Muscular Dystrophy | - | - |
POL6014 | Phase 2 | Cystic Fibrosis | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply